28.2 - Transcriptomic and metabolic profiling of Tolvaptan treated Autosomal dominant polycystic kidney disease (ADPKD) patient

Speaker(s)

• Hugo Lin

  Presenting Author
  Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University